Blume Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,500
| Closed | -$148K | – | 243 |
|
|
2019
Q3 | $148K | Hold |
1,500
| – | – | 0.07% | 79 |
|
|
2019
Q2 | $139K | Sell |
1,500
-200
| -12% | -$19K | 0.07% | 78 |
|
|
2019
Q1 | $160K | Sell |
1,700
-215
| -11% | -$18.8K | 0.08% | 77 |
|
|
2018
Q4 | $123K | Buy |
1,915
+40
| +2% | +$2.95K | 0.07% | 83 |
|
|
2018
Q3 | $168K | Hold |
1,875
| – | – | 0.09% | 65 |
|
|
2018
Q2 | $149K | Hold |
1,875
| – | – | 0.08% | 67 |
|
|
2018
Q1 | $167K | Hold |
1,875
| – | – | 0.09% | 63 |
|
|
2017
Q4 | $196K | Hold |
1,875
| – | – | 0.1% | 66 |
|
|
2017
Q3 | $273K | Buy |
1,875
+875
| +88% | +$119K | 0.14% | 55 |
|
|
2017
Q2 | $130K | Hold |
1,000
| – | – | 0.07% | 64 |
|
|
2017
Q1 | $124K | Hold |
1,000
| – | – | 0.07% | 64 |
|
|
2016
Q4 | $116K | Hold |
1,000
| – | – | 0.07% | 67 |
|
|
2016
Q3 | $105K | Hold |
1,000
| – | – | 0.06% | 67 |
|
|
2016
Q2 | $99K | Hold |
1,000
| – | – | 0.07% | 70 |
|
|
2016
Q1 | $100K | Hold |
1,000
| – | – | 0.07% | 69 |
|
|
2015
Q4 | $120K | Hold |
1,000
| – | – | 0.08% | 68 |
|
|
2015
Q3 | $108K | Sell |
1,000
-200
| -17% | -$24.8K | 0.09% | 60 |
|
|
2015
Q2 | $139K | Hold |
1,200
| – | – | 0.11% | 56 |
|
|
2015
Q1 | $138K | Sell |
1,200
-200
| -14% | -$23.9K | 0.1% | 63 |
|
|
2014
Q4 | $157K | Buy |
1,400
+200
| +17% | +$21.1K | 0.11% | 63 |
|
|
2014
Q3 | $114K | Hold |
1,200
| – | – | 0.09% | 59 |
|
|
2014
Q2 | $103K | Hold |
1,200
| – | – | 0.08% | 67 |
|
|
2014
Q1 | $84K | Hold |
1,200
| – | – | 0.07% | 79 |
|
|
2013
Q4 | $101K | Buy |
+1,200
| New | +$95K | 0.08% | 75 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Blume Capital Management's CELG Position: Q4 2019 in Review
Blume Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,500 shares — an estimated $148K sold.
Blume Capital Management first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $273K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Blume Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Blume Capital Management sold 1,500 Celgene Corp shares in Q4 2019, an estimated $148K.
- Blume Capital Management first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
- Blume Capital Management's Celgene Corp position peaked at $273K in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Blume Capital Management's 13F filing for Q4 2019, filed 5 Feb 2020.